Naltrexone Implant for the Treatment of Polydrug Dependence: A Randomized Controlled Trial
American Journal of PsychiatryPublished 17 February 2012
Jari Tiihonen, Evgeny Krupitsky, E. Verbitskaya, Elena Blokhina, Olga Mamontova, Jaana Föhr
Citations93
SJR quartileQ1
SJR score5.27
SNIP3.68
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Naltrexone implants resulted in higher retention in the study, decreased heroin and amphetamine use, and improved clinical condition for patients, thus providing the first evidence of an effective pharmacological treatment for this type of polydrug dependence.
Abstract
Naltrexone implants resulted in higher retention in the study, decreased heroin and amphetamine use, and improved clinical condition for patients, thus providing the first evidence of an effective pharmacological treatment for this type of polydrug dependence.
Keywords
Medicine
Humana Press eBooksTimeline Follow-Back
3,982 Citations1992Linda C. Sobell, Mark B. Sobell
Concerns about how best to measure drinking patterns and problems date back to at least 1926, when Pearl stressed the importance of separating steady daily drinkers from occasional heavy drinkers.
The Journal of Nervous and Mental DiseaseAn Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
3,216 Citations1980A. Thomas McLellan, Lester Luborsky +2 more
The use of the ASI is suggested to match patients with treatments and to promote greater comparability of research findings, suggesting the treatment problems of patients are not necessarily related to the severity of their chemical abuse.
New England Journal of MedicineA Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
628 Citations2000Rolley E. Johnson, Mary Ann Chutuape +4 more
As compared with low-dose methadone, levomethadyl acetate, buprenorphine, and high-dose Methadone substantially reduce the use of illicit opioids.
New England Journal of MedicineNaltrexone in the Treatment of Alcohol Dependence
614 Citations2001John Krystal, Joyce A. Cramer +3 more
The findings do not support the use of naltrexone for the treatment of men with chronic, severe alcohol dependence.
JAMAEfficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence
612 Citations2005James C. Garbutt, Henry R. Kranzler +7 more
The LancetInjectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
540 Citations2011Evgeny Krupitsky, Edward V. Nunes +4 more
XR-NTX represents a new treatment option that is distinct from opioid agonist maintenance treatment and might improve acceptance of opioid dependence pharmacotherapy and provide a useful treatment option for many patients.
New England Journal of MedicineDiacetylmorphine versus Methadone for the Treatment of Opioid Addiction
381 Citations2009Eugenia Oviedo‐Joekes, Suzanne Brissette +5 more
Injectable diacetylmorphine maintenance therapy was more effective than oral methadone in patients with opioid dependence that was refractory to treatment and should be delivered in settings where prompt medical intervention is available.
Archives of General PsychiatryInjectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence
349 Citations2006Sandra D. Comer, Maria A. Sullivan +6 more
This formulation of naltrexone was well tolerated and produced a robust, dose-related increase in treatment retention, providing new evidence of the feasibility, efficacy, and tolerability of long-lasting antagonist treatments for opioid dependence.
Clinical Psychology ReviewA review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction
335 Citations2009Jennifer C. Veilleux, Peter Colvin +3 more
An up-to-date review of the literature on opioid dependence treatment, with a focus on evidence for inclusion of psychosocial approaches in treatment regimens, either as stand-alone or in conjunction with psychopharmacological options.
American Journal of PsychiatryNaltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial
180 Citations2008Nitya Jayaram‐Lindström, Anders Hammarberg +2 more
The main outcome measure was abstinence from amphetamine use, as indicated by the total number of negative amphetamine urine samples during 12 weeks of treatment, and survival analyses showed that the treatment groups differed in rate of continuous abstinence, in both the intention-to-treat and completer samples, in favor of naltrexone treatment.
The Canadian Journal of PsychiatryEvidence-Based Treatment of Opioid-Dependent Patients
146 Citations2006Wim van den Brink, Christian Haasen
Effective treatments are available to stabilize patients and reduce harm, thereby increasing life expectancy and quality of life, and both clinical experience and neurobiological evidence indicate that opioid dependence is a chronic relapsing disorder.
Archives of General PsychiatryImproving Clinical Outcomes in Treating Heroin Dependence
133 Citations2009Gary Kenneth Hulse, Noella Morris +2 more
The naltrexone implant effectively reduced relapse to regular heroin use compared with oral nALTrexone and was not associated with major adverse events.
AddictionSerious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)
105 Citations2004Erol Digiusto, Anthony Shakeshaft +3 more
Individuals who leave pharmacotherapies for opioid dependence experience higher overdose and death rates compared with those in treatment, and Clinicians should alert naltrexone treatment patients in particular about heroin overdose risks.
Current Psychiatry ReportsUse of Naltrexone to Treat Opioid Addiction in a Country in Which Methadone and Buprenorphine Are Not Available
103 Citations2010Evgeny Krupitsky, Edwin Zvartau +1 more
Naltrexone is more effective for relapse prevention and abstinence stabilization in Russia than in Western countries and long-acting, sustained-release formulations (injectable and implantable) seem particularly effective compared with oral formulations.
The British Journal of PsychiatryNaltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial
88 Citations2009Nikolaj Kun⊘e, Philipp Lobmaier +6 more
Naltrexone implant treatment safely and significantly reduces opioid use in a motivated population of patients.
Annals of the New York Academy of SciencesIntramuscular extended‐release naltrexone: current evidence
72 Citations2011David R. Gastfriend
Findings suggest that a formulation of naltrexone that was sought beginning over three decades ago is fulfilling its promise as an extended‐release pharmacotherapeutic.
CNS DrugsPharmacotherapy of Dual Substance Abuse and Dependence
66 Citations2007George A. Kenna, Darci M. Nielsen +3 more
While ondansetron and olanzapine show some efficacy in treating alcohol and cocaine dependence, more research is needed to better delineate the subpopulation in which these drugs may provide their maximum effect and to highlight the single drugs or drug combinations that show some potential for treating dual SUDs.
Current Opinion in PsychiatryLong-acting depot formulations of naltrexone for heroin dependence: a review
65 Citations2010Evgeny Krupitsky, Elena Blokhina
Long-acting sustained release formulations of naltrexone are well tolerated and more effective for relapse prevention in heroin addicts than the oral ones.
Journal of Substance Abuse TreatmentMortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment
58 Citations2007Robert J. Tait, Hanh Ngo +1 more
Overall mortality rates for naltrexone implant were similar to those for methadone, but increased mortality during methamphetamineadone induction was avoided.
European Addiction ResearchWhy Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine?
27 Citations2009David Otiashvili, Tomáš Zábranský +4 more
While widely misused by Georgian drug injectors, Subutex is neither the principal nor the favourite drug, and it is rather used as self-treatment.
European Addiction ResearchBioavailability of Buprenorphine from Crushed and Whole Buprenorphine (Subutex) Tablets
17 Citations2010Kaarlo Simojoki, Pirjo Lillsunde +2 more
The results indicate that crushing Subutex tablets may be used as an alternative method to counter the risk of buprenorphine diversion and the drug’s clinical effect.